List of Tables
Table 1. Global Genetically Engineered Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Genetically Engineered Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Genetically Engineered Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Genetically Engineered Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Genetically Engineered Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Genetically Engineered Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Genetically Engineered Vaccines Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Genetically Engineered Vaccines Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Genetically Engineered Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Genetically Engineered Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Genetically Engineered Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Genetically Engineered Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Genetically Engineered Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetically Engineered Vaccines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Genetically Engineered Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Genetically Engineered Vaccines Sales by Region (2020-2025) & (K Units)
Table 18. Global Genetically Engineered Vaccines Sales Market Share by Region (2020-2025)
Table 19. Global Genetically Engineered Vaccines Sales by Region (2026-2031) & (K Units)
Table 20. Global Genetically Engineered Vaccines Sales Market Share by Region (2026-2031)
Table 21. Global Genetically Engineered Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Genetically Engineered Vaccines Revenue Market Share by Region (2020-2025)
Table 23. Global Genetically Engineered Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Genetically Engineered Vaccines Revenue Market Share by Region (2026-2031)
Table 25. North America Genetically Engineered Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Genetically Engineered Vaccines Sales by Country (2020-2025) & (K Units)
Table 27. North America Genetically Engineered Vaccines Sales by Country (2026-2031) & (K Units)
Table 28. North America Genetically Engineered Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Genetically Engineered Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Genetically Engineered Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Genetically Engineered Vaccines Sales by Country (2020-2025) & (K Units)
Table 32. Europe Genetically Engineered Vaccines Sales by Country (2026-2031) & (K Units)
Table 33. Europe Genetically Engineered Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Genetically Engineered Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Genetically Engineered Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Genetically Engineered Vaccines Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Genetically Engineered Vaccines Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Genetically Engineered Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Genetically Engineered Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Genetically Engineered Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Genetically Engineered Vaccines Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Genetically Engineered Vaccines Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Genetically Engineered Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Genetically Engineered Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Genetically Engineered Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Genetically Engineered Vaccines Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Genetically Engineered Vaccines Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Genetically Engineered Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Genetically Engineered Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Genetically Engineered Vaccines Sales (K Units) by Type (2020-2025)
Table 51. Global Genetically Engineered Vaccines Sales (K Units) by Type (2026-2031)
Table 52. Global Genetically Engineered Vaccines Sales Market Share by Type (2020-2025)
Table 53. Global Genetically Engineered Vaccines Sales Market Share by Type (2026-2031)
Table 54. Global Genetically Engineered Vaccines Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Genetically Engineered Vaccines Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Genetically Engineered Vaccines Revenue Market Share by Type (2020-2025)
Table 57. Global Genetically Engineered Vaccines Revenue Market Share by Type (2026-2031)
Table 58. Global Genetically Engineered Vaccines Price (US$/Unit) by Type (2020-2025)
Table 59. Global Genetically Engineered Vaccines Price (US$/Unit) by Type (2026-2031)
Table 60. Global Genetically Engineered Vaccines Sales (K Units) by Application (2020-2025)
Table 61. Global Genetically Engineered Vaccines Sales (K Units) by Application (2026-2031)
Table 62. Global Genetically Engineered Vaccines Sales Market Share by Application (2020-2025)
Table 63. Global Genetically Engineered Vaccines Sales Market Share by Application (2026-2031)
Table 64. Global Genetically Engineered Vaccines Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Genetically Engineered Vaccines Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Genetically Engineered Vaccines Revenue Market Share by Application (2020-2025)
Table 67. Global Genetically Engineered Vaccines Revenue Market Share by Application (2026-2031)
Table 68. Global Genetically Engineered Vaccines Price (US$/Unit) by Application (2020-2025)
Table 69. Global Genetically Engineered Vaccines Price (US$/Unit) by Application (2026-2031)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Pfizer Genetically Engineered Vaccines Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Merck Company Information
Table 76. Merck Description and Business Overview
Table 77. Merck Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Merck Genetically Engineered Vaccines Product
Table 79. Merck Recent Developments/Updates
Table 80. GSK Company Information
Table 81. GSK Description and Business Overview
Table 82. GSK Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. GSK Genetically Engineered Vaccines Product
Table 84. GSK Recent Developments/Updates
Table 85. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Company Information
Table 86. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Description and Business Overview
Table 87. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Product
Table 89. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Recent Developments/Updates
Table 90. Walvax Biotechnology Co., Ltd. Company Information
Table 91. Walvax Biotechnology Co., Ltd. Description and Business Overview
Table 92. Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Product
Table 94. Walvax Biotechnology Co., Ltd. Recent Developments/Updates
Table 95. Bharat Biotech Company Information
Table 96. Bharat Biotech Description and Business Overview
Table 97. Bharat Biotech Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Bharat Biotech Genetically Engineered Vaccines Product
Table 99. Bharat Biotech Recent Developments/Updates
Table 100. Sanofi Company Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Sanofi Genetically Engineered Vaccines Product
Table 104. Sanofi Recent Developments/Updates
Table 105. Zoties Company Information
Table 106. Zoties Description and Business Overview
Table 107. Zoties Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Zoties Genetically Engineered Vaccines Product
Table 109. Zoties Recent Developments/Updates
Table 110. Elanco Company Information
Table 111. Elanco Description and Business Overview
Table 112. Elanco Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Elanco Genetically Engineered Vaccines Product
Table 114. Elanco Recent Developments/Updates
Table 115. Boehringer Ingelheim Company Information
Table 116. Boehringer Ingelheim Description and Business Overview
Table 117. Boehringer Ingelheim Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Boehringer Ingelheim Genetically Engineered Vaccines Product
Table 119. Boehringer Ingelheim Recent Developments/Updates
Table 120. Indian Immunologicals Company Information
Table 121. Indian Immunologicals Description and Business Overview
Table 122. Indian Immunologicals Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Indian Immunologicals Genetically Engineered Vaccines Product
Table 124. Indian Immunologicals Recent Developments/Updates
Table 125. China Animal Husbandry Industry Co.,Ltd. Company Information
Table 126. China Animal Husbandry Industry Co.,Ltd. Description and Business Overview
Table 127. China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Product
Table 129. China Animal Husbandry Industry Co.,Ltd. Recent Developments/Updates
Table 130. Yebio Bioengineering Co., Ltd Of Qingdao Company Information
Table 131. Yebio Bioengineering Co., Ltd Of Qingdao Description and Business Overview
Table 132. Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Product
Table 134. Yebio Bioengineering Co., Ltd Of Qingdao Recent Developments/Updates
Table 135. Jinyu Bio-technology Co.,ltd. Company Information
Table 136. Jinyu Bio-technology Co.,ltd. Description and Business Overview
Table 137. Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Product
Table 139. Jinyu Bio-technology Co.,ltd. Recent Developments/Updates
Table 140. HVRI Company Information
Table 141. HVRI Description and Business Overview
Table 142. HVRI Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. HVRI Genetically Engineered Vaccines Product
Table 144. HVRI Recent Developments/Updates
Table 145. Ringpu Biology Company Information
Table 146. Ringpu Biology Description and Business Overview
Table 147. Ringpu Biology Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Ringpu Biology Genetically Engineered Vaccines Product
Table 149. Ringpu Biology Recent Developments/Updates
Table 150. Kyoto Biken Laboratories Company Information
Table 151. Kyoto Biken Laboratories Description and Business Overview
Table 152. Kyoto Biken Laboratories Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Kyoto Biken Laboratories Genetically Engineered Vaccines Product
Table 154. Kyoto Biken Laboratories Recent Developments/Updates
Table 155. FATRO Company Information
Table 156. FATRO Description and Business Overview
Table 157. FATRO Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. FATRO Genetically Engineered Vaccines Product
Table 159. FATRO Recent Developments/Updates
Table 160. Ceva Santé Animale Company Information
Table 161. Ceva Santé Animale Description and Business Overview
Table 162. Ceva Santé Animale Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Ceva Santé Animale Genetically Engineered Vaccines Product
Table 164. Ceva Santé Animale Recent Developments/Updates
Table 165. Pulike Biological Engineering,Inc. Company Information
Table 166. Pulike Biological Engineering,Inc. Description and Business Overview
Table 167. Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Product
Table 169. Pulike Biological Engineering,Inc. Recent Developments/Updates
Table 170. Wuhan Hvsen Biotechnology CO.,LTD Company Information
Table 171. Wuhan Hvsen Biotechnology CO.,LTD Description and Business Overview
Table 172. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Product
Table 174. Wuhan Hvsen Biotechnology CO.,LTD Recent Developments/Updates
Table 175. Jinhe Biotechnology Co., Ltd. Company Information
Table 176. Jinhe Biotechnology Co., Ltd. Description and Business Overview
Table 177. Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 178. Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Product
Table 179. Jinhe Biotechnology Co., Ltd. Recent Developments/Updates
Table 180. Shanghai Shen Lian Biomedical Corporation Company Information
Table 181. Shanghai Shen Lian Biomedical Corporation Description and Business Overview
Table 182. Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 183. Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Product
Table 184. Shanghai Shen Lian Biomedical Corporation Recent Developments/Updates
Table 185. Qingdao Vland Biotech INC. Company Information
Table 186. Qingdao Vland Biotech INC. Description and Business Overview
Table 187. Qingdao Vland Biotech INC. Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 188. Qingdao Vland Biotech INC. Genetically Engineered Vaccines Product
Table 189. Qingdao Vland Biotech INC. Recent Developments/Updates
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Genetically Engineered Vaccines Distributors List
Table 193. Genetically Engineered Vaccines Customers List
Table 194. Genetically Engineered Vaccines Market Trends
Table 195. Genetically Engineered Vaccines Market Drivers
Table 196. Genetically Engineered Vaccines Market Challenges
Table 197. Genetically Engineered Vaccines Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
Table 201. Authors List of This Report
List of Figures
Figure 1. Product Picture of Genetically Engineered Vaccines
Figure 2. Global Genetically Engineered Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Genetically Engineered Vaccines Market Share by Type: 2024 & 2031
Figure 4. Genetic Recombinant Vaccine Product Picture
Figure 5. Recombinant Subunit Vaccines Product Picture
Figure 6. Genetic Vaccine Product Picture
Figure 7. Global Genetically Engineered Vaccines Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Genetically Engineered Vaccines Market Share by Application: 2024 & 2031
Figure 9. Veterinary Use
Figure 10. Human Use
Figure 11. Global Genetically Engineered Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Genetically Engineered Vaccines Market Size (2020-2031) & (US$ Million)
Figure 13. Global Genetically Engineered Vaccines Sales (2020-2031) & (K Units)
Figure 14. Global Genetically Engineered Vaccines Average Price (US$/Unit) & (2020-2031)
Figure 15. Genetically Engineered Vaccines Report Years Considered
Figure 16. Genetically Engineered Vaccines Sales Share by Manufacturers in 2024
Figure 17. Global Genetically Engineered Vaccines Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Genetically Engineered Vaccines Players: Market Share by Revenue in Genetically Engineered Vaccines in 2024
Figure 19. Genetically Engineered Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Genetically Engineered Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Genetically Engineered Vaccines Sales Market Share by Country (2020-2031)
Figure 22. North America Genetically Engineered Vaccines Revenue Market Share by Country (2020-2031)
Figure 23. United States Genetically Engineered Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Genetically Engineered Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Genetically Engineered Vaccines Sales Market Share by Country (2020-2031)
Figure 26. Europe Genetically Engineered Vaccines Revenue Market Share by Country (2020-2031)
Figure 27. Germany Genetically Engineered Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Genetically Engineered Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Genetically Engineered Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Genetically Engineered Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Genetically Engineered Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Genetically Engineered Vaccines Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Genetically Engineered Vaccines Revenue Market Share by Region (2020-2031)
Figure 34. China Genetically Engineered Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Genetically Engineered Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Genetically Engineered Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Genetically Engineered Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Genetically Engineered Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Genetically Engineered Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Genetically Engineered Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Genetically Engineered Vaccines Sales Market Share by Country (2020-2031)
Figure 42. Latin America Genetically Engineered Vaccines Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Genetically Engineered Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Genetically Engineered Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Genetically Engineered Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Genetically Engineered Vaccines Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Genetically Engineered Vaccines Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Genetically Engineered Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Genetically Engineered Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Genetically Engineered Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Genetically Engineered Vaccines by Type (2020-2031)
Figure 52. Global Revenue Market Share of Genetically Engineered Vaccines by Type (2020-2031)
Figure 53. Global Genetically Engineered Vaccines Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Genetically Engineered Vaccines by Application (2020-2031)
Figure 55. Global Revenue Market Share of Genetically Engineered Vaccines by Application (2020-2031)
Figure 56. Global Genetically Engineered Vaccines Price (US$/Unit) by Application (2020-2031)
Figure 57. Genetically Engineered Vaccines Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
